Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics

NCT02297230 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped PI Left Institution prior to reaching accrual goal and analyzing data.

Conditions

Breast Cancer

Interventions

RADIATION: Radiation Therapy (RT)
DRUG: Capecitabine
DRUG: Trastuzumab
DRUG: Paclitaxel

Sponsor

NYU Langone Health